The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy
The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy
复制标题
DOI：
10.1007/s12350-016-0538-8
复制
发表时间：
2016-08-01
影响因子：
2.4
通讯作者：
Schwartz, Ronald G.
中科院分区：
文献类型：
--
作者：
Russell, Raymond R.;Alexander, Jonathan;Schwartz, Ronald G.
随着越来越多的人生活在当前或先前诊断的癌症中，心血管专家必须认识到癌症的各种并发症及其对心血管系统的治疗。这不仅适用于已确立的癌症治疗，如蒽环类药物，这些药物具有明确的心血管毒性，而且适用于新的靶向治疗，这些治疗可能在心脏和血管中产生“脱靶”效应。本信息声明的目的是让心脏病专家、心脏影像学专家、心脏肿瘤学家和肿瘤学家了解多模态成像如何用于诊断和管理癌症治疗的心血管并发症。此外，本文件旨在提供有关癌症和癌症治疗的心血管并发症的有用一般信息，以及特定心脏毒性治疗监测的建议。
With the increasing number of individuals living with a current or prior diagnosis of cancer, it is important for the cardiovascular specialist to recognize the various complications of cancer and its therapy on the cardiovascular system. This is true not only for established cancer therapies, such as anthracyclines, that have well established cardiovascular toxicities, but also for the new targeted therapies that can have "off target" effects in the heart and vessels. The purpose of this informational statement is to provide cardiologists, cardiac imaging specialists, cardio-oncologists, and oncologists an understanding of how multimodality imaging may be used in the diagnosis and management of the cardiovascular complications of cancer therapy. In addition, this document is meant to provide useful general information concerning the cardiovascular complications of cancer and cancer therapy as well as established recommendations for the monitoring of specific cardiotoxic therapies.